BrainEver is a startup founded in 2015 based in France. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Developing hEN1 & hOTX2 homeoproteins to halt ALS (Charcot), Parkinson’s & Retina. Secures €33M Series B. View pipeline.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.